|
GSKâs Emerging Markets strategy advances with acquisition in Egypt
|
20 October 2008 |
|
GSK responds to NICE's second technology appraisal consultation document on the use of Tyverb
|
15 October 2008 |
|
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement
|
29 August 2008 |
|
GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration
|
29 July 2008 |
|
GlaxoSmithKline teams up with academia to develop new medicines of value
|
22 July 2008 |
|
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
|
02 July 2008 |
|
Cervarixâ¢, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme
|
23 June 2008 |
|
GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc.
|
09 June 2008 |
|
First pre-pandemic vaccine approved to help protect against pandemic influenza
|
20 May 2008 |
|
Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial
|
14 May 2008 |